Playback speed
10 seconds
ACR Convergence 2023 Highlights: Two Studies: TAK-279 (Tyk2) in PsA and Apremilast MRI Study in PsA
By
RheumNow
FEATURING
Guillermo Valenzuela
By
RheumNow
FEATURING
Guillermo Valenzuela
0 views
December 14, 2023
The above content is not sponsored by, nor part of, the American College of Rheumatology.
Comments 0
Login to view comments.
Click here to Login